Sun Pharma Q4 results 2026: Profit jumped 26% YoY to ₹2,714 crore. Total revenue from operations for the quarter under review rose 12.8% YoY to ₹14,611.79 crore. Sun Pharma’s board recommended a final dividend of ₹5 per share of ₹l each.
Source :- mint – markets Read More
